The Potential Implications of a PCOS Diagnosis on a Woman's Long-Term Health Using Data Linkage
The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
CONTEXT: The polycystic ovary syndrome (PCOS) is the commonest endocrine abnormality in women of reproductive age. OBJECTIVE: To determine the rate of hospital admissions for women with PCOS in Western Australian population in comparison to women without PCOS. DESIGN: A population-based retrospective cohort study using data linkage in a statewide hospital morbidity database system. SETTING: All hospitals within Western Australia. PARTICIPANTS: A total of 2566 women with PCOS hospitalized from 1997-2011 and 25 660 randomly selected age-matched women without a PCOS diagnosis derived from the electoral roll. MAIN OUTCOME MEASURES: Hospitalizations by ICD-10-M diagnoses from 15 years were compared. RESULTS: Hospitalizations were followed until a median age of 35.8 years (interquartile range, 31.0-39.9). PCOS was associated with more nonobstetric and non-injury-related hospital admissions (median, 5 vs 2; P < .001), a diagnosis of adult-onset diabetes (12.5 vs 3.8%), obesity (16.0 vs 3.7%), hypertensive disorder (3.8 vs 0.7%), ischemic heart disease (0.8 vs 0.2%), cerebrovascular disease (0.6 vs 0.2%), arterial and venous disease (0.5 vs 0.2% and 10.4 vs 5.6%, respectively), asthma (10.6 vs 4.5%), stress/anxiety (14.0 vs 5.9%), depression (9.8 vs 4.3%), licit/illicit drug-related admissions (8.8 vs 4.5%), self-harm (7.2 vs 2.9%), land transport accidents (5.2 vs 3.8%), and mortality (0.7 vs 0.4%) (all P < .001). Women with PCOS had a higher rate of admissions for menorrhagia (14.1 vs 3.6%), treatment of infertility (40.9 vs 4.6%), and miscarriage (11.1 vs 6.1%) and were more likely to require in vitro fertilization (17.2 vs 2.0%). CONCLUSION: PCOS has profound medical implications for the health of women, and health care resources should be directed accordingly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The prevalence of malignant cancer has been reported to be 2-fold greater or not different in those with PCOS.6,32”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [6]
In the citing paper
“The prevalence of endometrial cancer has been reported to be increased 3-5 fold in those with PCOS in the postmenopause years, and an increased risk for ovarian cancer has been reported in younger women with PCOS in the premenopause years.6,123, 124, 125”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [6]
In the citing paper
“Higher rates of endometriosis among women with PCOS (up to 70%) have been reported among women hospitalized for PCOS34 or with self-reported infertility and/or pelvic pain,21”
From Examining the co-occurrence of endometriosis and polycystic ovarian syndrome (2023) · cites this paper as [34]
In the citing paper
“Our data showed that mental health and psychiatric disorders had a 30% higher prevalence in those with PCOS, consistent with findings of previous population cohort studies.6,29,31,32,126,127”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [6]
In the citing paper
“The diagnosis of PCOS included the ICD-9 and ICD-10 codes, and these have been validated and used in previous epidemiologic studies.6,10,17,27,32,55, 56, 57”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [6]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976 · cited 6×
“experience a lower quality of life (2, 41, 42) and are prone”
BackgroundResultInfluentialLegro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919 · cited 2×
“tional Health and Medical Research Council (3), and in the United States by The Endocrine Society statement (4).”
BackgroundLegro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257
Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108 · cited 1×
“Our finding of a four times greater prevalence of type II diabetes among women with PCOS admitted to hospital is in agreement with the literature (2, 37).”
ResultHolman, C. D. J., Bass, A. J., Rouse, I. L., & Hobbs, M. S. T. (1999) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1467-842x.1999.tb01297.x · Cited by 1,037 · cited 1×
“org/data-linkage/ data-collections) within the linked data from the WA Data-Linkage System that has been validated previously and used extensively for health research (26).”
MethodWild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010
Stepto, N. K., Cassar, S., Joham, A. E., Hutchison, S. K., Harrison, C. L., Goldstein, R. F., & Teede, H. J. (2013) · Human Reproduction · doi:10.1093/humrep/des463 · Cited by 747 · cited 2×
“This data linkage study cannot determine causality, only associations; however, insulin resistance is more prevalent in women with PCOS and may occur in up to 75% of lean women with PCOS (34), and it is believed that insulin resistance is integral to the underlying pathophysiology of the cardiometabolic perturbation i…”
Background
Cited by
Items 301–390 of 390
Tharwat, O., Bakr, E. H., Ghoneim, H. M., & Tharwat, O. (2020) · Case Reports in Obstetrics Gynecology and Reproductive · doi:10.31487/j.crogr.2019.01.02 · Cited by 2
“It is established that PCOS trigger multiple systems affection on the long term such as cardiovascular incidents, type 2 diabetes mellitus, metabolic syndrome, in addition to infertility [2, 3].”
BackgroundHamadneh, J., Al-Bayyari, N. S., Hamadneh, S., Al-Zeidaneen, S. A., Subih, H. S., Burgan, S., & Amarin, Z. O. (2020) · International Journal of Women s Health and Reproduction Sciences · doi:10.15296/ijwhr.2021.05 · Cited by 2
“Finally, previous studies have consistently reported that the tHcy level in women with PCOS is not related to the degree of obesity, insulin resistance, or androgen levels (4,25), which conforms to the findings of the current study.”
BackgroundResultInfluentialOocyte quality evaluation and cryopreservation
Özcan, P., Varlı, B., Fındıklı, N., Başar, M., & Oral, E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89907-9.00004-1 · Cited by 3
Overview of the Comorbidity Between Medical Illnesses and Overweight/Obesity
Nolan, C. J. (2019) · Springer eBooks · doi:10.1007/978-3-030-32545-9_4 · Cited by 2
Elucidating the roles of naturally occurring silent mutations in Polycystic Ovary Syndrome (PCOS)
Gümüşgül, M. D., Şahin, Ş., Turan, H., Karaca, B. T., & Kutlu, A. (2020) · Meta Gene · doi:10.1016/j.mgene.2020.100707 · Cited by 1
Hodé, A. K., Denakpo, J. L., Hubert, D. A., Dakin, M., & Techeme, E. (2022) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2022.1212020 · Cited by 1
Guo, Y., Dai, F., Zheng, B., Tao, L., & Cui, T. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-06173-5 · Cited by 1
“More patients with PCOS than those without the condition need assisted reproduction techniques (ARTs) therapy [1].”
BackgroundA preemptive approach to polycystic ovary syndrome diagnosis using machine learning
Agarwal, S., Kumar, N., & Chauhan, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21870-5.00038-8 · Cited by 1
Liu, Q., Hu, K.-L., Shi, J., Yang, S., Chu, Y., Wang, H., Zhang, Y., Jing, Y., Hao, G., Wu, X., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-093543 · Cited by 1
The impact of androgens on pregnancy and fetal outcomes in patients with polycystic ovary syndrome
Tammo, Ö., Söylemez, E., Kızıldemir, Y. Z., İNCEBIYIK, M., & Sak, M. E. (2025) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.70056 · Cited by 3
“5 – 7 However, the precise mechanisms and long-term effects of this relationship are not yet fully understood.”
Oliva, M. M., Nordio, M., Picconi, O., & Porcaro, G. (2025) · Multidisciplinary Respiratory Medicine · doi:10.5826/mrm.2025.1051 · Cited by 3
“In addition, some observational studies have stated that acute respiratory failure or uncontrolled asthma attacks are the primary cause of hospitalization for non-gynecological reasons in PCOS patients [18].”
MASLD coexisting with PCOS increases cardiometabolic risk
Ayonrinde, O. T., Mori, T. A., Adams, L. A., Beilin, L. J., Olynyk, J. K., & Hart, R. J. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag008 · Cited by 2
Self-citationTale, A. D., Lokwani, D. K., Mandade, K. S., Borikar, S. P., Kanthale, S. B., Shelke, S. P., & Jain, S. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-04975-w · Cited by 2
Increased mortality in polycystic ovary syndrome— a cohort study
Piltonen, T., Koskenkari, N. V. S., Koivuaho, E., Morin-Papunen, L. C., Hurskainen, E., Gissler, M., Arffman, R. K., & Ollila, M. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag080 · Cited by 2
Belchin, P., Calvente, V., Roso, M. J. G., Exposito, E. M. G., Bueno, A. S., Fluge, M. A., & Pérez, D. O. (2026) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2026.2681759 · Cited by 2
Luteinizing hormone is a primary culprit in the endometrial carcinoma development in elderly women
Rao, C. V. (2016) · Journal of Reproductive Health and Medicine · doi:10.1016/j.jrhm.2016.06.001 · Cited by 1
Akison, L. K., Andraweera, P. H., Bertoldo, M. J., Brown, H. M., Cuffe, J. S. M., Fullston, T., Holland, O. J., & Schjenken, J. E. (2016) · Reproduction Fertility and Development · doi:10.1071/rd16382 · Cited by 1
Koç, B. L., & TİMUR, B. (2021) · Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi · doi:10.37989/gumussagbil.1003117 · Cited by 1
Li, S., Li, J., Ai, Q., & Liu, H. (2022) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2022.2054682 · Cited by 1
“Women with PCOS could exhibit a range of minor to severe symptoms, which can have a far-reaching impact on reproductive health and the extended health of her offspring (Mayor 2015; Hart and Doherty 2015; Qin et al. 2013).”
BackgroundGraca, S., Armour, M., & McClure, L. S. (2022) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2022.102161 · Cited by 1
Barabasz-Gembczyk, A., Mędrala, W., Rodek, P., Alli-Balogun, B., Chrobak, J., Cwynar, M., Sikora, D., Wójtowicz, M., Franik, G., Madej, P., et al. (2023) · Metabolites · doi:10.3390/metabo13050646 · Cited by 1
Fatima, Q., Jeelani, H., Abass, S., Farooq, M., & Rashid, F. (2023) · Springer eBooks · doi:10.1007/978-981-99-2193-5_9 · Cited by 3
The Adjunct Role of Anti Mullerian Hormone (AMH) in Diagnosing Polycystic Ovary Syndrome
Alsolaiman, L. A., Khaddam, W., & Hussein, Y. A. (2024) · Zagazig Journal of Pharmaceutical Sciences/Zagazig Journal of Pharmaceutical Science · doi:10.21608/zjps.2024.263254.1060 · Cited by 1
McGlacken-Byrne, S. M., Gunn, H. M., & Simpson, H. (2024) · Endocrinology · doi:10.1007/978-3-030-23709-7_29 · Cited by 1
Radwan, A. M., Youssry, M. A., Elsaadany, H. M., & Patel, T. A. (2017) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20172554 · Cited by 3
“It can be considered as a risk factor for metabolic syndrome-related comorbidities and for impaired wellbeing and mortality.(2)”
BackgroundEffects of progesterone treatment in polycystic ovary syndrome on pulmonary functions
Yaman, F. K., & Arslan, S. (2019) · Turkish Bulletin of Hygiene and Experimental Biology · doi:10.5505/turkhijyen.2019.46656 · Cited by 2
Pharmacotherapy and Neoteric Dietary Approaches for Polycystic Ovary Syndrome: A Systematic Review
MALİK, T. H., ALİ, H., Hassan, A., QAYYUM, J., & NASEEM, A. (2021) · Endocrinology research and practice. · doi:10.25179/tjem.2020-78987 · Cited by 3
Cardiometabolic risk in women with PCOS
Carmina, E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00016-x · Cited by 2
Frequency of Polycystic Ovary Disease in Adolescent
Gul, N., Bibi, N., Ghafoor, M., Babar, R., & Anbreen, F. (2023) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2023172512 · Cited by 1
Polycystic ovary syndrome: the competence of a family doctor
Artyomenko, V., Velychko, V. I., Lahoda, D. O., Nastradina, N. M., & Nitochko, K. (2023) · Reproductive Endocrinology · doi:10.18370/2309-4117.2023.67.63-67 · Cited by 2
Song, Y., Deng, Y. P., Chung, J. P. W., Li, T. C., Wang, C. C., Li, H., Yang, T., Sui, Y., & Tang, T. (2021) · Research Square · doi:10.21203/rs.3.rs-1046361/v1 · Cited by 1
Polar Body, Cleavage Stage and Trophectoderm Biopsy
Capalbo, A., Rienzi, L. F., Cimadomo, D., & Ubaldi, F. M. (2017) · CRC Press eBooks · doi:10.1201/9781315157269-16
INFLAMMATORY GENE EXPRESSION IN WOMEN DIAGNOSED WITH POLYCYSTIC OVARIAN SYNDROME
Taylor, M. K. (2016) · Pittsburg State University Digital Commons (Pittsburg State University)
PCOS: Implications of Cardiometabolic Dysfunction
Fauser, B. C. J. M. (2017) · ISGE series · doi:10.1007/978-3-319-63540-8_10 · Cited by 1
Infertility and Subfertility Cofactors in Women with PCOS
Shavit, T., & Tulandi, T. (2017) · Springer eBooks · doi:10.1007/978-3-319-45534-1_6
Risk factors for venous thromboembolism in women
Тутченко, Т. Н., Татарчук, Т. Ф., Родионова, И. А., & Regeda, S. I. (2018) · Reproductive Endocrinology · doi:10.18370/2309-4117.2018.41.12-24
The Role of the Glucocorticoid Receptor Signalling Pathway within the Human Endometrium
Thomas, S. J. (2019) · Cronfa (Swansea University) · doi:10.23889/suthesis.50584
Recurrent pregnancy loss at gynecology and obstetrical hospital in Duhok Province
Abdulrahman, I. J., Jawad, A. K., & Amin, N. A. S. M. (2020) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20203511 · Cited by 2
“1% in PCOS and control groups, respectively.(20)”
Onwuzurumba, K. K. (2020) · UA Campus Repository (The University of Arizona) · Cited by 1
[Research progress on the role of pentraxin 3 in polycystic ovary syndrome].
Wu, W., & Xu, J. (2020) · PubMed Central · doi:10.3785/j.issn.1008-9292.2020.08.13
Polycystic Ovary Syndrome in Adolescents
Roman, R. A., Asiaii, A., Rambhatla, A., Miranda-Silva, C., & NEZHAT, C. R. (2020) · Springer eBooks · doi:10.1007/978-3-030-52984-0_25
Prevalence of Asthma in Polycystic Ovary Syndrome Women: A Meta-analysisPreprint
Sun, H., Li, D., Jiao, J., Liu, Q., Bian, J., & Wang, X. (2020) · Research Square · doi:10.21203/rs.3.rs-122458/v1
“6 articles were nally included in the meta-analysis[20-25].”
BackgroundPregnancy Complications & Management Related to Polycystic Ovarian Syndrome: An Overview
Davande, C. C., Gade, A. R., & Kanekar, A. S. (2021) · Cited by 1
Prevention of Cardiovascular Disease
Sharma, G. V., Minhas, A., & Michos, E. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819369-3.00013-7
Patten, R. K. (2021) · Victoria University Research Repository (Victoria University) · Cited by 5
Long-term health in women of age more than 40 years with polycystic ovary syndrome
Armeni, E., & Lambrinoudaki, I. V. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00003-1
Diagnostic Evaluation of Polycystic Ovarian Disease
Nadia, A., Hanif, A., Rafique, S., Ashfaq, M., & Faiyaz, M. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22163356
Palomba, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-45534-1_1
Cancer and Polycystic Ovary Syndrome
Hardiman, P. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108989831.020
Imam, A. M. A., Sabra, A. M. A., Nasr, A. M. A. A., & Fetih, A. N. H. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns7.11516
Koç, B. L., TİMUR, B., Yumuşak, Ö. H., & Yeşilyurt, H. (2022) · Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi · doi:10.47572/muskutd.947753
In Vitro Maturation for Clinical Use
Walls, M. L., & Hart, R. J. (2017) · CRC Press eBooks · doi:10.1201/9781315157269-10
Self-citationAssociation Of The LH/FSH Ratio With Electrocardiogram Abnormalities In Polycystic Ovarian SyndromePreprint
Wu, L., Zheng, S., Zhao, G., Tian, B., Sun, Y.-C., Tan, Y. C., Tang, X., Qian, X., & Chen, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-2141531/v1
Song, Y., Deng, Y. P., Chung, J. P. W., Li, T. C., Wang, C. C., Li, H., Yang, T., Sui, Y., & Tang, T. (2022) · Research Square · doi:10.21203/rs.3.rs-1046361/v2
Velvizhi, S., & Annapurani, S. (2021) · The Indian Journal of Nutrition and Dietetics · doi:10.21048/ijnd.2021.58.s1.27546
Data continuity and linkage in the healthcare ecosystem
Charles, W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824010-6.00020-4 · Cited by 1
SOPK, une pathologie fréquente, et mal nommée
Bouchard, P. (2023) · Elsevier eBooks · doi:10.1016/b978-2-294-78134-6.00012-7
Síndrome de ovario poliquístico, más allá de una afección en la reproducción.
Fuentes-Ibarra, J., Valencia‐Ortega, J., González-Reynoso, R., & Saucedo, R. (2023) · Educación y Salud Boletín Científico Instituto de Ciencias de la Salud Universidad Autónoma del Estado de Hidalgo · doi:10.29057/icsa.v12i23.10678 · Cited by 3
PREGNANCY COMPLICATIONS AND OUTCOMES IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
Rahim, G. (2022) · Journal of Sulaimani Medical College · doi:10.17656/jsmc.10367
Husin, H., Yussof, M. A. M., Hamid, A., Ishak, I., & Budin, S. B. (2023) · Sains Malaysiana · doi:10.17576/jsm-2023-5212-10 · Cited by 1
McGlacken-Byrne, S. M., Gunn, H. M., & Simpson, H. (2023) · Endocrinology · doi:10.1007/978-3-030-18901-3_29-1
Menstruation: Myths, Mechanisms, Models and Malfunctions
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4935-3
The Correlation Between Abnormal Uterine Bleeding in Early Menarche and PCOS Later in Adolescence
Deligeoroglou, E., & Karountzos, V. (2024) · ISGE series · doi:10.1007/978-3-031-55300-4_4
Übersicht über die Komorbidität zwischen medizinischen Erkrankungen und Übergewicht/Fettleibigkeit
Nolan, C. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-55637-1_4
Ren, Z., Chen, W., & Huang, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-4492462/v1
Association Between Obesity in Women, Polycystic Ovary Syndrome and Adverse Obstetric Outcome
Ginod, P., & Dahan, M. H. (2024) · Springer eBooks · doi:10.1007/978-3-031-62491-9_6
Contraception et syndrome des ovaires polykystiques
Chakhtoura, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-2-294-78270-1.00023-5
Różewicz, M., Ganbat, M., Nagel, E. C., & Püntmann, V. O. (2024) · Current Cardiovascular Imaging Reports · doi:10.1007/s12410-024-09598-4
Bashir, K., Ahmad, M., Saif, S., Sharif, M., Niazi, U. K., Shahzadi, R., & Iftikhar, A. (2025) · Gene Reports · doi:10.1016/j.genrep.2025.102139 · Cited by 4
Polycystic Ovary Syndrome and Labor Market Attachment: Sequence Analysis
Boldis, B. V., Grünberger, I., Helgertz, J., & Cederström, A. (2025) · International Journal of Public Health · doi:10.3389/ijph.2025.1607889 · Cited by 1
Percy, C. A., Turner, A., Alper, B., & Wark, P. A. (2026) · JMIR Formative Research · doi:10.2196/69206
“While often considered a concern of the reproductive years, PCOS is lifelong, with enduring health consequences such as increased risks of type 2 diabetes, cardiovascular disease, and endometrial cancer [19-23].”
Phypers, R., & Hanna, R. (2025) · Photonics · doi:10.3390/photonics12101021
“Women with PCOS are not only more likely to have endometriosis (26.4 vs. 4.4%), but the combined diagnosis is likely to result in an increased likelihood of infertility [12].”
InfluentialEngaging longitudinal cohort participants in a research priority setting process for the Raine Study
Paolis, M. D., Abdul, S., McKenzie, A., Glauert, R. A., Cayley, G., Bucks, R. S., & Wood, D. (2025) · Research Involvement and Engagement · doi:10.1186/s40900-025-00805-0 · Cited by 1
Diagnosis of PCOS in Special Situations
Singh, M., Madan, A., Singh, H., & Tanvir, T. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898810931125010008
Amiri, M., Ramezani Tehrani, F., Behboudi‐Gandevani, S., Bidhendi-Yarandi, R., & Carmina, E. (2020) · Figshare · doi:10.6084/m9.figshare.11998881
Sadecki, E. N., Weaver, A., Zhao, Y., Stewart, E. A., & Ainsworth, A. J. (2022) · Figshare · doi:10.6084/m9.figshare.18666682
Additional file 1 of Comorbidities in women with polycystic ovary syndrome: a sibling study
Boldis, B. V., Grünberger, I., Cederström, A., Björk, J., Nilsson, A., & Helgertz, J. (2024) · Figshare · doi:10.6084/m9.figshare.26702497
Sydora, B. C., Wilke, M. S., McPherson, M., Chambers, S. A., Ghosh, M., & Vine, D. F. (2024) · Figshare · doi:10.6084/m9.figshare.26635785
Purohit, A., Kushwaha, P., Roy, A., Harkal, P., Prajapati, S., Sahoo, B., Kashaw, S. K., & Soni, V. (2025) · INDIAN DRUGS · doi:10.53879/id.62.10.15551
Chen, Y., Yang, G., Zhang, Y.-N., Li, X., Yu, Y.-N., De, S., Guo, R.-X., Ren, J., Li, X.-N., Shi, Y.-H., et al. (2026) · Molecular Human Reproduction · doi:10.1093/molehr/gaag003
Asadollahi, Z., Ghaheri, A., Haji‐Maghsoudi, S., Haghdoost, A., Ashrafi, M., Eftekhari‐Yazdi, P., & Jahani, Y. (2026) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v23i12.20715
“The SZINB further indicated that other ovarian abnormalities significantly lowered the probability of producing high-quality oocytes, emphasizing the critical role of ovarian health in fertility outcomes (25, 26).”
Омариевна, У. Ф., & Demidova, T. Y. (2026) · FOCUS Endocrinology · doi:10.62751/2713-0177-2026-7-1-09
Complicações gestacionais e perinatais em mulheres com síndrome dos ovários policísticos
Carneiro, J. D. S., & Silva, A. C. J. D. S. R. E. (2021) · Femina · doi:10.61622/0100-7254499202103 · Cited by 7
Ainsworth, A. J., Missmer, S. A., Barbieri, R. L., & GOLDMAN, M. B. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45863-7.00027-5
The Manifestation of Non-Suicidal Self-Injury in Women with Polycystic Ovary Syndrome (PCOS)Preprint
Fido, D., Williams, S., & Sheffield, D. (2026) · Research Square · doi:10.21203/rs.3.rs-10676014/v1
Romeo, P., Freger, S., Kalani, N., Shishkina, A., Aharoni, S., Shetty, R., & Leonardi, M. (2026) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.70289
Polycystic ovary syndrome: from hormonal imbalance to psychological problems
Романченко, А. А., & Sulima, A. N. (2026) · Сибирский научный медицинский журнал · doi:10.18699/ssmj20260404
Konan, B. H., & Üstün, Y. (2026) · Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi · doi:10.20492/aeahtd.1973408
Sydora, B. C., Ghosh, M., Chambers, S., Haase, A., Davenport, M. H., Beaulieu, C., Thompson, R. B., Windram, J., Becher, H., Raggi, P., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-124025
Piltonen, T., Teede, H. J., & Khomami, M. B. (2026) · Human Reproduction · doi:10.1093/humrep/deag150
Metadata
- Authors
- Hart, R., & Doherty, D. A.
- Affiliations
- The University of Western Australia (AU)
- Corresponding author
- Hart, Roger
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-03
- Volume
- 100
- Issue
- 3
- Pages
- 911-919
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2098409670
- Cited by
- 391
- References
- 51
- Citations by year
- 2026: 17 · 2025: 22 · 2024: 39 · 2023: 35 · 2022: 45 · 2021: 41 · 2020: 43 · 2019: 38 · 2018: 34 · 2017: 32 · 2016: 33 · 2015: 12
- FWCI
- 31.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Keywords
- polycystic ovary syndrome, long-term health effects, hospitalization, type 2 diabetes, obesity, depression, anxiety, infertility, miscarriage, in vitro fertilization, menorrhagia, mortality, Western Australia, healthcare resource allocation, data linkage, women's health, vascular disease
- MeSH terms
- Adolescent, Adult, Australia, Data Collection, Female, Hospitalization, Humans, Middle Aged, Polycystic Ovary Syndrome, Pregnancy, Time Factors, Comorbidity, Case-Control Studies, Young Adult, Reproductive Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.